66 related articles for article (PubMed ID: 1779110)
21. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
22. [The potential for organ-preserving treatment in large uveal melanoma].
Terent'eva LS; Fokin VP
Oftalmol Zh; 1989; (6):338-41. PubMed ID: 2622597
[TBL] [Abstract][Full Text] [Related]
23. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
24. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
[TBL] [Abstract][Full Text] [Related]
25. Eye-wall resection.
Char DH; Miller T; Crawford JB
Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
[TBL] [Abstract][Full Text] [Related]
26. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
27. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
[TBL] [Abstract][Full Text] [Related]
28. Brachytherapy of choroidal melanomas.
Brady LW; Hernandez JC
Strahlenther Onkol; 1992 Feb; 168(2):61-5. PubMed ID: 1542847
[TBL] [Abstract][Full Text] [Related]
29. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
Finger PT; Berson A; Szechter A
Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
[TBL] [Abstract][Full Text] [Related]
30. [Double irradiation for macroscopic radioresistance or recurrence of melanomas of the posterior uvea: clinical, ballistic, therapeutic and prognostic aspects. Series of 19 cases among 462 patients].
Grange JD; Duquesne N; Roubeyrol F; Branisteanu D; Sandon K; Fleury J; Gerard JP; Chauvel P; Pinzaru G; Jean-Louis B; Bievelez B
J Fr Ophtalmol; 1999 Dec; 22(10):1054-63. PubMed ID: 10617843
[TBL] [Abstract][Full Text] [Related]
31. Early macular morphological changes following plaque radiotherapy for uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA
Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032
[TBL] [Abstract][Full Text] [Related]
32. [Surgical management of ciliary body melanoma].
Romanowska-Dixon B
Klin Oczna; 2005; 107(10-12):627-31. PubMed ID: 16619806
[TBL] [Abstract][Full Text] [Related]
33. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
34. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
Isager P; Ehlers N; Urbak SF; Overgaard J
Acta Oncol; 2006; 45(3):285-93. PubMed ID: 16644571
[TBL] [Abstract][Full Text] [Related]
35. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
36. [Report on the conservative treatment of melanoma of the uvea at the Lausanne University Ophthalmologic Clinic].
Zografos L; Gailloud C; Perret C; Uffer S; Raimondi S; Chamot L; Carrel S; Greiner R
Klin Monbl Augenheilkd; 1988 May; 192(5):572-8. PubMed ID: 3404968
[TBL] [Abstract][Full Text] [Related]
37. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
[TBL] [Abstract][Full Text] [Related]
38. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
39. [Conservative treatment of choroidal melanoma using iodine-125 brachytherapy, technique and preliminary analysis of 78 patients].
Quétin P; Meyer L; Schumacher C; Polto F; Magnenet P; Andres E; Sahel J; Schraub S
Cancer Radiother; 2001 Dec; 5(6):737-42. PubMed ID: 11797294
[TBL] [Abstract][Full Text] [Related]
40. Amniotic membrane corneal buffering during plaque radiation therapy for anterior uveal melanoma.
Semenova E; Finger PT
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(5):477-82. PubMed ID: 24044711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
